Cargando…

Early Sirolimus-Based Immunosuppression is Safe for Lung Transplantation Patients: Retrospective, Single Arm, Exploratory Study

BACKGROUND: Sirolimus, a mechanistic target of sirolimus inhibitor, is an immunosuppression medication for patients undergoing heart and abdominal transplantation. Sirolimus-based immunosuppression administered de novo post-lung transplantation is associated with bronchial anastomosis healing-relate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wojarski, Jacek, Żegleń, Sławomir, Ochman, Marek, Karolak, Wojtek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248054/ https://www.ncbi.nlm.nih.gov/pubmed/30135417 http://dx.doi.org/10.12659/AOT.908471

Ejemplares similares

Serum Levels of Visfatin, Omentin and Irisin in Patients with End-Stage Lung Disease Before and After Lung Transplantation
por: Ochman, Marek, et al.
Publicado: (2017)

A functional assessment of patients two years after lung transplantation in Poland
por: Jastrzębski, Dariusz T., et al.
Publicado: (2014)

A Single-Center Experience with Lung Transplants During the COVID-19 Pandemic
por: Karolak, Wojtek, et al.
Publicado: (2021)

Use of Sensitive, Broad-Spectrum Molecular Assays and Human Airway Epithelium Cultures for Detection of Respiratory Pathogens
por: Pyrc, Krzysztof, et al.
Publicado: (2012)

Osteoporosis in patients referred for lung transplantation
por: Jastrzebski, D, et al.
Publicado: (2010)

HTCC: Broad Range Inhibitor of Coronavirus Entry
por: Milewska, Aleksandra, et al.
Publicado: (2016)

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
por: Kirby, Sean, et al.
Publicado: (2012)

APOBEC3-mediated restriction of RNA virus replication
por: Milewska, Aleksandra, et al.
Publicado: (2018)

A Prospective, Multinational Pharmacoepidemiological Study of Clinical Conversion to Sirolimus Immunosuppression after Renal Transplantation
por: Kasiske, Bertram L., et al.
Publicado: (2012)

Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy
por: Foroutan, Naghmeh, et al.
Publicado: (2013)

Impact of Sirolimus as a Primary Immunosuppressant on Myocardial Fibrosis and Diastolic Function Following Heart Transplantation
por: Alnsasra, Hilmi, et al.
Publicado: (2020)

Exploratory study of autophagy inducer sirolimus for childhood cerebral adrenoleukodystrophy
por: Luo, Xiao-Mei, et al.
Publicado: (2023)

Novel coronavirus-like particles targeting cells lining the respiratory tract
por: Naskalska, Antonina, et al.
Publicado: (2018)

Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study
por: Asleh, Rabea, et al.
Publicado: (2022)

Survival Associated With Sirolimus Plus Tacrolimus Maintenance Without Induction Therapy Compared With Standard Immunosuppression After Lung Transplant
por: Wijesinha, Marniker, et al.
Publicado: (2019)

The Benefit of Sirolimus Maintenance Immunosuppression and Rabbit Antithymocyte Globulin Induction in Liver Transplant Recipients That Develop Acute Kidney Injury in the Early Postoperative Period
por: Duhart, Benjamin T., et al.
Publicado: (2015)

Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study
por: Feng, Yimei, et al.
Publicado: (2020)

A 12-Month Single Arm Pilot Study to Evaluate the Efficacy and Safety of Sirolimus in Combination with Tacrolimus in Kidney Transplant Recipients at High Immunologic Risk
por: Lee, Juhan, et al.
Publicado: (2015)

De novo Renal Transplantation after Kaposi Sarcoma: Favorable Outcome in a Patient Receiving Sirolimus and Mycophenolate-Based Immunosuppression
por: Friedersdorff, F., et al.
Publicado: (2010)

Nanomedicines in renal transplant rejection – focus on sirolimus
por: Shen, Li-Jiuan, et al.
Publicado: (2007)

Autophagy in kidney transplants of sirolimus treated recipients
por: Bhayana, Sagar, et al.
Publicado: (2017)

Sirolimus in renal transplant recipients with malignancies in Germany
por: Naik, Marcel G, et al.
Publicado: (2020)

The Nucleocapsid Protein of Human Coronavirus NL63
por: Zuwała, Kaja, et al.
Publicado: (2015)

Retrospective cohort study of patients qualified for lung transplantation due to idiopathic pulmonary fibrosis – single-centre experience
por: Ochman, Marek, et al.
Publicado: (2019)

Renal Outcomes of Liver Transplantation Recipients Receiving Standard Immunosuppression and Early Renal Sparing Immunosuppression: A Retrospective Single Center Study
por: Sharma, Pratima, et al.
Publicado: (2019)

Hemopericardium in a Sirolimus-Treated Renal Transplant Patient
por: Groudan, Kevin, et al.
Publicado: (2020)

Sirolimus-Induced Rash in a Kidney Transplant Patient
por: Bruss, Zachary, et al.
Publicado: (2022)

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)

Sirolimus-Based Immunosuppression as GvHD Prophylaxis after Bone Marrow Transplantation for Severe Aplastic Anaemia: A Case Report and Review of the Literature
por: Perruccio, Katia, et al.
Publicado: (2015)

Minimally invasive aortic valve replacement – pros and cons of keyhole aortic surgery
por: Kaczmarczyk, Marcin, et al.
Publicado: (2015)

Alloimmune haemolysis in a renal transplant recipient receiving sirolimus
por: Hedley, Adam J., et al.
Publicado: (2008)

Sirolimus-induced interstitial pneumonitis in a renal transplant recipient
por: Kanaan, Nada, et al.
Publicado: (2008)

The Effect Of Covid-19 Infection On Sirolimus Metabolism In Heart Transplant
por: Patalinghug, Paul, et al.
Publicado: (2023)

Immunosuppressant Adherence Factors Differentiating Compliant and Non-Compliant Kidney Transplant Recipients
por: Ostrowski, Piotr, et al.
Publicado: (2023)

Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy
por: Khanna, Ashwani, et al.
Publicado: (2002)

Drug Interaction between Sirolimus and Ranolazine in a Kidney Transplant Patient
por: Masters, Joanna C., et al.
Publicado: (2014)

Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA)
por: Ozeki, Michio, et al.
Publicado: (2019)

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
por: Schnitzbauer, Andreas A, et al.
Publicado: (2010)

Sirolimus therapy following early cyclosporine withdrawal in transplant patients: mechanisms of action and clinical results
por: Thervet, Eric
Publicado: (2006)

COVID-19 Among Lung Transplant Recipients: A Single Center Study
por: Ochman, Marek, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2sher4fbskrahtfsbu5m570m7v